Neko Health

We've raised a $700M Series C, led by @lightspeedvp and co-led by O.G. Venture Partners. Since 2023, more than 350,000 people have signed up for a Neko Health Scan, and 100,000 people have experienced one. Today, our approach to redefining how people understand and act on their health is already working: for returning members, our data shows that 5 out of 7 of their key health markers showed statistically significant improvement between scans. This funding will scale our research into the hidden causes of disease and the development of proprietary technology to detect it before it has time to develop. It will also fund our continued expansion, including to the US, where our first clinic is set to open in New York this year. This round comes weeks after our biggest update yet to the Neko Health Scan, with body composition measures and clinician review of wearable data now included in all scans across our clinics in the UK and Sweden. We're grateful for the continued support of @atomico, @generalcatalyst, and Lakestar, and welcome new investors including Liberty City Ventures, Positive Sum, and BDT & MSD Partners.

We've raised a $700M Series C, led by @lightspeedvp and co-led by O.G. Venture Partners. Since 2023, more than 350,000 people have signed up for a Neko Health Scan, and 100,000 people have experienced one. Today, our approach to redefining how people understand and act on their health is already working: for returning members, our data shows that 5 out of 7 of their key health markers showed statistically significant improvement between scans. This funding will scale our research into the hidden causes of disease and the development of proprietary technology to detect it before it has time to develop. It will also fund our continued expansion, including to the US, where our first clinic is set to open in New York this year. This round comes weeks after our biggest update yet to the Neko Health Scan, with body composition measures and clinician review of wearable data now included in all scans across our clinics in the UK and Sweden. We're grateful for the continued support of @atomico, @generalcatalyst, and Lakestar, and welcome new investors including Liberty City Ventures, Positive Sum, and BDT & MSD Partners.

Today we're announcing that @Neko has raised a $700M Series C. @eldsjal and I started the company with the belief that the solution to the trickiest problems in healthcare won't come from scaling the existing system. Medicine has spent centuries getting good at treating disease. The next medical frontier will be understanding health and making sure things are not going wrong in the first place. To proactively find problems you need to find when things start to change, and to do we need a completely new approach to tracking health over time. You cannot solve this by just adding more software to the existing system. Diagnostic technology needs to become faster, cheaper and more accurate. Data needs to be understood continuously. Doctors need better tools and more time with each person. That's why at Neko, we've rebuilt the entire stack: medical devices, sensors, AI, software, clinical protocols and clinics run by our own staff. Our first product, the Neko Health Scan, maps millions of health data points and gives members their results in a single 60-minute visit. More than 100,000 people have now experienced it. This new funding will help us advance the quality and affordability of preventive care by orders of magnitude. We are expanding into the US, starting in New York City, and taking on some of the hardest problems in medicine: earlier detection, deeply personalized care, better health outcomes and new insights into the drivers of chronic disease. Our goal is to make healthcare proactive by default. This funding will help get us there faster.